Multiple functions of HMGB1 in cancer

被引:7
|
作者
Lv, Guangyao [1 ]
Yang, Menglin [2 ]
Gai, Keke [1 ]
Jia, Qiong [1 ]
Wang, Zhenzhen [1 ]
Wang, Bin [1 ]
Li, Xueying [3 ]
机构
[1] Binzhou Med Univ Hosp, Dept Pharm, Binzhou, Shandong, Peoples R China
[2] Marine Biomed Res Inst Qingdao, Qual Management Dept, Qingdao, Peoples R China
[3] Binzhou Polytech, Sch Hlth, Binzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
HMGB1; cancer; chemotherapy resistance; autophagy; immunotherapy; GROUP BOX 1; IMMUNOGENIC CELL-DEATH; HMGB1-MEDIATED AUTOPHAGY; PROTEIN HMGB1; ANGIOGENESIS; CHEMOTHERAPY; RESISTANCE; EXPRESSION; PROGRESSION; MIGRATION;
D O I
10.3389/fonc.2024.1384109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] HMGB1: A pleiotropic activity
    Colavita, Laura
    Ciprandi, Giorgio
    Salpietro, Annamaria
    Cuppari, Caterina
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 : 63 - 65
  • [42] HMGB1 release by inflammasomes
    Vande Walle, Lieselotte
    Kanneganti, Thirumala-Devi
    Lamkanfi, Mohamed
    VIRULENCE, 2011, 2 (02) : 162 - 165
  • [43] CLINICAL SIGNIFICANCE OF HMGB1 EXPRESSION IN HUMAN GASTRIC CANCER
    Zhang, J.
    Zhang, R.
    Lu, W. W.
    Zhu, J. S.
    Xia, L. Q.
    Lu, Y. M.
    Chen, N. W.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (04) : 543 - 551
  • [44] The cytokine activity of HMGB1
    Yang, H
    Wang, HC
    Czura, CJ
    Tracey, KJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (01) : 1 - 8
  • [45] HMGB1 and injury amplification
    Huebener, Peter
    Hernandez, Celine
    Schwabe, Robert F.
    ONCOTARGET, 2015, 6 (27) : 23048 - 23049
  • [46] Is HMGB1 an osteocyte alarmin?
    Bidwell, Joseph P.
    Yang, Jieping
    Robling, Alexander G.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (06) : 1671 - 1680
  • [47] HMGB1 loves company
    Bianchi, Marco E.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (03) : 573 - 576
  • [48] The roles of HMGB1 related angiogenesis and lymphangiogenesis in oral cancer
    Sasahira, Tomonori
    Yamamoto, Kazuhiko
    Kurihara, Miyako
    Bhawal, Ujjal K.
    Chihara, Yoshitomo
    Kirita, Tadaaki
    Kuniyasu, Hiroki
    ONCOLOGY REVIEWS, 2011, 5 (01) : 49 - 55
  • [49] HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
    Chen, Mingkun
    Zhu, Li
    Xue, Miao
    Zhu, Rongrong
    Jing, Liling
    Wang, Huaizhou
    Qin, Yanghua
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer
    Li, Pan
    Xu, Mengfei
    Cai, Hongbing
    Thapa, Niresh
    He, Can
    Song, Ziye
    BIOSCIENCE REPORTS, 2019, 39